Extracorporeal Shock Wave Lithotripsy Market Growth Accelerated by Rising Prevalence of Kidney Stones Disease
 |
| Extracorporeal Shock Wave Lithotripsy Market |
Extracorporeal shock wave
lithotripsy (ESWL) is a non-invasive medical procedure used to treat kidney
stones and other types of calculi (stones formed from minerals or calcium
salts) located in the kidney, ureter, or bile ducts. Kidney stones form when
there is a decrease in urine volume or an excess of stone-forming substances in
the urine, allowing minerals to crystallize and gather in the kidneys or
urinary tract. The global extracorporeal shock wave lithotripsy market is
estimated to be valued at US$ 443 Mn in 2023 and is expected to exhibit a CAGR
of 7.2% over the forecast period 2023 to 2030, as highlighted in a new report
published by Coherent Market Insights.
Market Dynamics:
Growing prevalence of kidney
stones is expected to drive the global extracorporeal shock wave lithotripsy
market growth over the forecast period. According to National Kidney Foundation
Inc., kidney stones affect approximately 1 in 11 people at some time during
their life. Moreover, increased sugary beverages consumption and inadequate
water intake are some of the major causes responsible for rising incidence of
kidney stones. This has resulted in increased demand for minimally invasive
treatment procedures such as extracorporeal shock wave lithotripsy over complex
surgeries. Additionally, development of technologically advanced lithotripters
by key players offering high efficiency and success rates are also expected to
aid in market growth. For instance, Dornier MedTech's Spark lithotripter
utilizes digital focused shockwave technology to treat kidney stones
efficiently at lower energies, thus reducing treatment time and complexity.
SWOT Analysis
Strength: Extracorporeal shock
wave lithotripsy is a minimally invasive treatment for kidney stones. It allows
for fragmentation of kidney stones without incisions, reducing recovery time.
The procedure can often be done as an outpatient treatment. Patients are able
to resume regular activities soon after treatment.
Weakness: There is a risk of
stone fragments remaining after treatment that may require additional
procedures or surgical intervention. Some patients may also experience
bruising, discomfort or bleeding at the treatment site. Treatment success
depends on stone size, composition and location which impacts fragmentation.
Opportunity: Growing geriatric
population prone to developing kidney stones present an opportunity for growth
of lithotripsy procedures. Rising prevalence of obesity and lifestyle diseases
increases risk of kidney stones, driving demand. Technological advancements
allowing treatment of larger and harder stones expand the scope of minimally
invasive lithotripsy.
Threats: Availability of
competing treatments like ureteroscopy and percutaneous nephrolithotomy limits
adoption of lithotripsy in some cases. Presence of reimbursment issues in some
countries poses challenges.
Key Takeaways
The Global
Extracorporeal Shock Wave Lithotripsy Market Demand is expected to
witness high growth over the forecast period of 2023 to 2030 supported by
rising disease burden.
The regional analysis indicates
that North America accounts for the largest share of the extracorporeal shock
wave lithotripsy market in 2023 valued at US$ 180 Mn. Europe is the second
largest regional market driven by supportive reimbursement policies and
healthcare infrastructure.
Key players operating in the extracorporeal shock wave lithotripsy
market are William Grant & Sons, Pernod Ricard, Diageo Plc, Bacardi
Limited, Suntory Holdings, and Aceo Ltd. Other notable players are Ben Nevis
Distillery, Edrington, Louis Vuitton Moët Hennessy and Gordon & MacPhail.
Major companies are focused on technological advancements to develop more
efficient lithotripsy machines allowing treatment of wider range of stones.
Partnerships are also allowing expanded geographical presence and access to new
markets.
Get More Insights Here
Comments
Post a Comment